NumerixS Investment Technologies’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

NumerixS Investment Technologies’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-1,900	Closed	-$56K	–	1401
2020 Q1	$56K	Buy	+1,900	New	+$64.3K	0.03%	590
2019 Q3	–	Sell	-3,365	Closed	-$81K	–	1363
2019 Q2	$81K	Sell	3,365 -6,635	-66%	-$168K	0.02%	661
2019 Q1	$262K	Buy	+10,000	New	+$237K	0.04%	575
2018 Q4	–	Sell	-15,175	Closed	-$296K	–	1533
2018 Q3	$296K	Sell	15,175 -2,725	-15%	-$51.8K	0.06%	450
2018 Q2	$294K	Buy	17,900 +6,500	+57%	+$99.1K	0.07%	404
2018 Q1	$160K	Buy	+11,400	New	+$168K	0.04%	493
2016 Q2	–	Sell	-67,867	Closed	-$1.13M	–	1298
2016 Q1	$1.13M	Buy	67,867 +17,484	+35%	+$306K	0.13%	213
2015 Q4	$1.09M	Sell	50,383 -32,917	-40%	-$641K	0.14%	188
2015 Q3	$1.65M	Buy	+83,300	New	+$2.63M	0.19%	117
2015 Q1	–	Sell	-24,988	Closed	-$322K	–	731
2014 Q4	$322K	Buy	+24,988	New	+$313K	0.11%	277

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

NumerixS Investment Technologies's HZNP Position: Q2 2020 in Review

NumerixS Investment Technologies sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q2 2020, closing a stake of 1,900 shares — an estimated $56K sold.

NumerixS Investment Technologies first reported a position in HZNP in Q4 2014 and held it in 10 quarters. The position peaked at $1.65M in Q3 2015. 354 funds tracked by Wall St. Rank hold HZNP as of Q2 2020.

NumerixS Investment Technologies reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q2 2020 after selling out during the quarter.
NumerixS Investment Technologies sold 1,900 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q2 2020, an estimated $56K.
NumerixS Investment Technologies first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2014 and held it in 10 quarters.
NumerixS Investment Technologies's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $1.65M in Q3 2015.
354 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q2 2020.

Based on NumerixS Investment Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.